Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Market Closed - BME Other stock markets 16:37:59 12/06/2026 BST			5-day change	1st Jan Change
58.80 ^EUR	+1.29%		0.00%	-7.40%

05-13	Spanish stocks - Factors to watch on May 13	RE
05-09	Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.48B		BBB
ELI LILLY AND COMPANY	1,010B		A
JOHNSON & JOHNSON	580B		BBB
ABBVIE INC.	402B	-	AA	-		-
ROCHE HOLDING AG	330B		AA
NOVARTIS AG	281B		AAA
ASTRAZENECA PLC	280B		A
NOVO NORDISK A/S	197B		A
AMGEN INC.	192B		A
GILEAD SCIENCES, INC.	156B		AA
PFIZER INC.	149B		A
BRISTOL-MYERS SQUIBB COMPANY	117B		A
VERTEX PHARMACEUTICALS INCORPORATED	113B		AA
SANOFI	106B		AA
GSK PLC	106B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	76.54B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	50.12B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	47.41B		AA
BAYER AG	41.16B		AA
Average	215.15B		AA
Weighted average by Cap.			AA